Evidence map›Paper›PMID 40420217›Full record

ArticleOne health outlook2025

Molecular characterization of multidrug-resistant Escherichia coli in the Greater Accra Region, Ghana: a 'One Health' approach.

Michael A Olu-Taiwo, Beverly Egyir, Christian Owusu-Nyantakyi, Akua Obeng Forson, Japheth A Opintan

Abstract read
In one paragraph

Article in One health outlook, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Michael A Olu-TaiwoDepartment of Medical Laboratory Science, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Legon Accra, Ghana. molu-taiwo@ug.edu.gh.ORCID http://orcid.org/0000-0001-8164-3080
Beverly EgyirBacteriology Department, Noguchi Memorial Institute for Medical Research, Accra, Ghana.
Christian Owusu-NyantakyiBacteriology Department, Noguchi Memorial Institute for Medical Research, Accra, Ghana.
Akua Obeng ForsonDepartment of Medical Laboratory Science, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Legon Accra, Ghana.
Japheth A OpintanDepartment of Medical Microbiology, Ghana Medical School, College of Health Sciences, University of Ghana, Legon Accra, Ghana.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background"One Health," a concept that highlights the need to bring on board multiple players and actors together to address major health problems, has been proposed to be effective in data gathering to mitigate the menace of antimicrobial drug resistance (AMR). Genomic data on extended-spectrum beta-lactamase-producing Escherichia coli (ESBL-EC) across humans, animals, and the environment are limited in low- and middle-income countries (LMICs), including Ghana.

objectiveThis study determined the prevalence and patterns of AMR in E. coli from diverse sources, and characterized AMR genes, sequence types (STs), and plasmid replicon types in ESBL-EC. METHODOLOGY: In a cross-sectional study, we randomly collected 1500 specimens from healthy humans, cattle, pigs, lettuce, spring onions, pork, beef, and soil samples, between January 2022 - April 2023. E. coli was isolated by routine culture and confirmed by MALDI-TOF MS. E. coli isolates were screened for their susceptibility against 13 antimicrobial agents and ESBL-production. ESBL-EC isolates were whole-genome sequenced (WGS), and in silico analysis was used to determine AMR genes, sequence types (STs), and plasmid replicon types.

resultOf the 1500 specimens from diverse sources cultured, 140 (9.3%) were positive for E. coli. No E. coli was isolated from lettuce, spring onions, and pork. Fifty (35.7%) E. coli isolates were resistant to three or more of the antimicrobials tested, and 30 (21.4%) were ESBL-EC. The proportion of ESBL-EC identified in healthy humans were 14 (20%), cattle 9 (22.5%), pigs 3 (15%), beef 1 (50%) and soil 3 (37.5%). ESBL-EC isolates were highly resistant to ampicillin (100%), cefuroxime (100%), ciprofloxacin (53.6%), and tetracycline (58.2%). However, all ESBL-EC were susceptible to meropenem. Commonly detected AMR genes were blaTEM-1B (32%), tetA (48%) and sul2 (32%), with majority recovered from healthy human and soil samples. The dominant sequence types found were 12% (3) for ST10, ST 9312, ST 206, and ST 4151. The prevalent plasmid replicon types detected were IncFIB (Apoo1918) (40%) and IncFII (pCoo) (36%).

conclusionWithin the metropolis surveyed, we identified MDR ESBL-EC harbouring various AMR genes and plasmid replicon types with diverse E. coli sequence types in healthy humans, animals, and the environment. The detection of blaCTX-M-15 in agricultural soil isolate is worrisome, emphasizing the need for a "One Health" approach in combating AMR.

Indexed as

Antimicrobial resistance (AMR)Escherichia coli (E. coli)Extended-spectrum-beta-lactamase (ESBL)GhanaMulti-drug resistant (MDR)

Identifiers

PMID40420217
PMCPMC12107756

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.